ALKT vs FORTY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ALKT's deterministic health scores signal significant financial distress: the Piotroski F-Score of 2/9 indicates weak operational and financial health, while the absence of an Altman Z-Score raises concerns about bankruptcy risk. Despite strong revenue growth of 34.7% YoY and a gross margin of 57.84%, the company remains unprofitable with negative ROE (-13.25%), ROA (-4.72%), and a profit margin of -10.74%. Insider selling totaling $1.54M over six months, coupled with a bearish technical trend and a 52-week price decline of 28.8%, underscores deteriorating sentiment. The stock trades at a premium valuation (P/B 5.28, Forward P/E 16.31) despite negative earnings, suggesting overvaluation relative to fundamentals.
FORTY exhibits significant financial fragility, highlighted by a weak Piotroski F-Score of 2/9, indicating deteriorating fundamental health. The stock is trading at a substantial premium, with a current price of $124.45 nearly double its Graham Number ($67.88) and Intrinsic Value ($67.85). While the company maintains a low Debt/Equity ratio, the unsustainable dividend payout ratio of 107.08% and a bearish technical trend (0/100) suggest a high risk of price correction. Extreme volatility in earnings growth and stagnant revenue growth (2.4% YoY) further undermine the current valuation.
Compare Another Pair
Related Comparisons
ALKT vs FORTY: Head-to-Head Comparison
This page compares Alkami Technology, Inc. (ALKT) and Formula Systems (1985) Ltd. (FORTY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.